🔬 SIVE has extreme pricing power with 60% gross margins, compared to LITE's ~45-48%, and is at the early stage of a CPO supercycle with exponentially growing revenue pipelines

high convictionFirst mentioned Mar 18, 2026 at $8.92

SIVE has extreme pricing power with 60% gross margins, compared to LITE's ~45-48%, and is at the early stage of a CPO supercycle with exponentially growing revenue pipelines.

Evidence & details
Evidence
  • +60% gross margins for $SIVE is extreme pricing power
  • +exponentially growing revenue pipelines
  • +very beginning of the CPO supercycle
  • +CEO statement: 'We do not look at competitors when demand far outstrips supply' (from context)
Catalysts
  • CPO supercycle
  • Demand far outstripping supply (CEO statement)
  • Revenue pipeline growth
Risks
  • Potential margin compression from competition or scaling
  • Execution risk in meeting demand

Chart

Post Timeline · 72 posts

new thesishigh

@ram_blings Not 1:1 but $LITE gross margins are ~45-48%. Having 60% gross margins for $SIVE is extreme pricing power. And that’s on top of exponentially growing revenue pipelines… at the very beginning of the CPO supercycle.

Thesis: SIVE has extreme pricing power with 60% gross margins, compared to LITE's ~45-48%, and is at the early stage of a CPO supercycle with exponentially growing revenue pipelines.

thesis updatehigh

@KPACTAFXAMCTEP Thanks for asking that question. What an absolutely legendary response from $SIVE CEO. And this type of answer around demand just derisks Sivers a ton.

Thesis: SIVE CEO's comments on demand outstripping supply and high gross margins derisk the company and indicate strong pricing power.

thesis updatehigh

Holy crap, this is the most bullish thing I’ve heard from $SIVE so far. From earnings transcripts: “We do not look at competitors when demand far outstrips supply” (literally anything they make gets bought) Along with: “We see 60% gross margins in the future” (incredibly hig…

Thesis: SIVE shows extreme pricing power with demand outstripping supply, targets 60% gross margins, and has two technologies feeding into three supercycles, indicating massive revenue opportunities.

new thesishigh

$SIVE basically took their entire revenue pipeline. In the entire company’s history. Then grew that by 77% in the first 3 months. Thats by far the clearest indication of the inflection of the CPO supercycle. It’s probably going to look exponential from here on out. https://t…

Thesis: SIVE's entire revenue pipeline grew 77% in first 3 months, indicating CPO supercycle inflection likely leading to exponential growth.

new thesishigh

@DeJeff48985 Extremely bullish on $SIVE. I’m very brutally honest when it comes to earnings reports on the names I own. We got 77% forward growth indications from the entire company’s pipelines… over a single quarter. $JBL ramp confirmation. Then multiple volume ramp produ…

Thesis: SIVE's earnings report shows 77% forward growth indications, $JBL volume ramp confirmation, and multiple production starts, marking the inflection point of the CPO supercycle with exponential growth e…

new thesishigh

@BigKaiWang Sequential 77% growth. Basically entire company revenue pipeline from all these years. And it increased 77% in the first few months of 2026. Absurd forward growth indications coming from $SIVE.

Thesis: Sequential 77% growth in forward revenue pipeline indicates massive forward growth for SIVE, validating volume ramp expectations and CPO supercycle.

thesis updatehigh

@dockery58 Thanks, I’m still waiting on the transcript to come out. But glad they clarified $JBL volume ramp is coming and photonics is their main growth vector. Great thesis validation so far.

Thesis: Validation of SIVE thesis with $JBL volume ramp as photonics growth vector confirmed by management.

thesis updatehigh

@RyanU_1F42B This is 77% growth, from literally the start of the CPO supercycle H1 2026. I’d expect that number to just keep on compounding exponentially as we approach H2 2027, which is the true inflection of scale up CPO.

Thesis: $SIVE's 77% sequential revenue growth marks the start of the CPO supercycle, with expectations of exponential compounding through H2 2027.

thesis updatehigh

@cobra_mindset1 77% growth in 1 single quarter. From the entire company’s operating history to date. I’m not sure if markets realize how high that is and represents a structural shift in forward revenue growth indications. Extremely positive in regards to $SIVE thesis validatio…

Thesis: 77% sequential growth in forward revenue projections validates volume ramp expectations for $SIVE in the CPO supercycle.

thesis updatehigh

@chrisoc9999 77% growth of forward revenue projections… Over a single quarter is absurdly high growth. And validates volume ramp expectations with $SIVE. Just want you want to hear from qualification cycle players, along with “multiple volume ramp” production start. And that s…

Thesis: Forward revenue projections grew 77% in a single quarter, validating volume ramp expectations for SIVE. Multiple volume ramps are starting and will compound growth further.

thesis updatehigh

Only thing to look at with $SIVE earnings is forward growth. Nobody cares about pre-development contract earnings from 2025 or last quarter, especially for qualification cycle optical players. Having 77% growth of opportunity pipelines (revenue volume ramp projections), to $79…

Thesis: Forward growth from volume ramp in photonics is accelerating, with 77% growth in opportunity pipeline to $799m in a single quarter, validating the volume ramp thesis.

new thesishigh

$SIVE is the most compelling CPO/photonics exposure to me. Addressing the disinformation: I haven’t sold and don’t plan to sell a single share. I do think this ends up the next $80B+ $LITE one day from ~$2.1B. And I personally have plans to acquire more ownership + support th…

Thesis: SIVE is the most compelling CPO/photonics exposure with strong catalysts including AlChip/Amazon private placements, Wiwynn CPO scale-up, JBL optical transceiver ramp, O-Net scaling, YSS acquisition, …

noise

@cchronobreakk I have something planned for $HOOD retail users and international equities like $SIVE, don’t worry.

Thesis: User mentions planned content or activity involving $HOOD retail users and $SIVE international equities, but provides no specific thesis or analysis.

view on X ↗HOOD · SIVE
thesis updatehigh

@159Adir52550 CPO is largely h2 2027. $JBL already announced timelines for mass production on their 1.6T LRO using $SIVE so that’s material revenue coming in within 3-10m.

Thesis: JBL's mass production of 1.6T LRO using SIVE will generate material revenue in 3-10 months.

new thesishigh

@BgEdgelord $SIVE is fundamentally extremely compelling from CPO. And all the valuation drivers are $JBL 1.6T and CPO ramp from players like Ayar. Think those shorts turning into a long are just a cherry on top along the way.

Thesis: SIVE is fundamentally compelling due to CPO technology, with valuation drivers from JBL's $1.6T opportunity and CPO ramp from players like Ayar. Short interest turning into long positions is an additi…

new thesishigh

$JBL literally announced in their fireside chat… Mass production of their 1.6T LRO with excessive demand in 3-10 months. $SIVE is likely sole source laser supplier for this specific optical transceiver. Ayar raised $500M for volume ramp recently, and $SIVE is the primary / s…

Thesis: Sivers Semiconductors is likely the sole source laser supplier for Jabil's 1.6T LRO optical transceivers, with mass production expected in 3-10 months. Additional volume ramps with Ayar, AEVA, and POE…

new thesishigh

@Ecom_Venture2 $SIVE is highest possible upside, since I see them being the next $LITE (which started at ~$2.6B as well in 2024, but now is $80B). As laser chokepoints are known to downstream TAM expand, then vertically integrate assembly/fabs after. Foci/Shunsin I kinda expe…

Thesis: Sivers Semiconductors ($SIVE) is positioned to become the next Lumentum ($LITE), with massive upside potential as a laser chokepoint benefiting from TAM expansion and vertical integration.

new thesishigh

For people trying to do valuation analysis on $SIVE. Ayar, Celestial, Lightmatter, Lightelligence are probably valued probably ~$4B-15B+ today. Sivers is ~$2.6B MC and they're likely upstream laser for them all. I'm not even including Poet, TFLN links like Hyperlight/Lightiu…

Thesis: Sivers Semiconductors (SIVE) is undervalued relative to private CPO players like Ayar, Celestial, Lightmatter, Lightelligence, given its position as a key laser supplier. Upcoming NASDAQ listing and p…

new thesishigh

@yvesai0 Nah, I think $SIVE is still extremely undervalued relatively speaking. Ayar, Lightmatter, Lightelligence, celestial, and others all probably command $5-$15B+ valuations. Not even including small guys like $POET or pluggables like $JBL. Sivers lasers likely power them…

Thesis: Sivers lasers are undervalued relative to the high valuations of their customers (Ayar, Lightmatter, Lightelligence, etc.) because Sivers is likely the primary/sole source for many critical components…

new thesishigh

@notrickflair No, why would there be much of a pullback? (Also don’t own Cerebras) The “hype” over Vanguard and Blackrock buying $SIVE is extremely justified… Because that’s new + pure buying pressure into existing float. And inflows are probably another $10M+ now next week giv…

Thesis: Institutional buying by Blackrock and Vanguard next week will create pure buying pressure into existing float, with estimated $10M+ inflows due to market cap increase.

new thesishigh

Did you listen anon? $SIVE is extremely early. And we’re about to see a ton of institutional inflow (Blackrock, Vanguard, MSCI, NASDAQ) next week for the first time. Then, couple that with NASDAQ listing soon, with even more US institutions entering. This is what it’s like …

Thesis: SIVE is extremely early and poised for significant institutional inflow from Blackrock, Vanguard, MSCI, NASDAQ next week, followed by a NASDAQ listing that will attract more US institutions. The setup…

thesis updatehigh

@ThriveSnap $SIVE is extremely early. Before it was mainly retail. All the institutional capital are about to enter soon, as seen with all the index inflows next week. Then NASDAQ soon. Retail just aren’t accustomed to being the earliest to a name for once.

Thesis: SIVE is extremely early with retail holding now, but institutional capital (index inflows, NASDAQ inclusion) is about to enter, driving further upside.

new thesishigh

$SIVE is the largest beneficiary of brand new events this weekend: 1. Sivers new NASDAQ index inclusion (OMX Stockholm): Both Vanguard and Blackrock are new passive inflows. With ~$60M+ pure buying pressure inflow, into existing float, together with MSCI next week. 2. US Gov …

Thesis: SIVE is the largest beneficiary of NASDAQ index inclusion, passive inflows from Vanguard/Blackrock, US-Sweden tech collaboration, and CHIPS Act awards, providing strong fundamental and institutional s…

new thesismedium

几个值得重点关注的“实质性垄断”标的: - MSSCORP (6830):在检测和 CPO 良率把控上构筑了极深的专利护城河。 - $SOI:主导绝缘体上硅 (SOI) 衬底市场。 - NGK (5333):稳拿薄膜铌酸锂 (TFLN) 晶圆核心技术。 - $AXTI:把控磷化铟 (InP) 衬底等上游关键材料。 像讯芯 (Shunsin) 这类公司其实很难被轻易颠覆,毕竟背靠富士康,而富士康本身就深深扎根于众多核心供应链的腹地 🏭 $SIVE 的逻辑也极其相似。他们已经成功打入 (design in) 了众多顶尖 CPO 架构的设计体系…

Thesis: 多个实质性垄断标的被列为重点关注,包括MSSCORP、SOI、NGK、AXTI,其中$SIVE逻辑类似,已打入顶尖CPO设计体系。同时提示$HIMX未来存在被踢出局(design out)的风险,但短期内仍有机会。

view on X ↗MSSCORP · SOI · NGK · AXTI · SIVE · HIMX
new thesishigh

Fun fact: Lot of the same companies are often used across different supply chains. One likely example is: $SIVE as the upstream laser supplier to Boston Dynamics via: Sivers -> $AEVA FMCW (CW DFB lasers) -> LG Innotek -> Boston Dynamics. I actually personally liked Aeva for 4…

Thesis: Sivers (SIVE) is an upstream laser supplier to Boston Dynamics via Aeva and LG Innotek, with near-term revenue ramp from supplying lasers for Nvidia's self-driving car architectures through Aeva. The …

new thesishigh

@vas_203 $SIVE (laser), Foci (fau/optical components), Shunsin (packaging/test), MSSCorp (yields) are personally my favorites right now for CPO related stuff. Since they all basically go from 0 to 100 full steam ahead in the next 2 years.

Thesis: Bullish on SIVE for CPO related stuff as it goes from 0 to 100 in next 2 years.

new thesishigh

AI capex spend is expected to go to "$3 to $4 trillion annually" by 2030 from $NVDA Jensen Huang projections. You're not bullish enough. And it might be a good idea to stay exposed + own the keys of the AI Kingdom: -> $AXTI controls the materials buildout with photonics. -> …

Thesis: AI capex growth to $3-$4 trillion annually by 2030 will benefit companies controlling key AI buildout components: photonics, silicon photonics, laser chokepoints, epiwafer supply chains, neoclouds, an…

view on X ↗AXTI · SOI · SIVE · IQE · NBIS · MU · SNDK
new thesishigh

I’m not selling a single share of $SIVE. I personally think it’s a once-a-generation long given how many hyperscaler suppliers they’re already in. Coupled with GS extreme TAM expansion projections for both pluggables and CPO in the next 2 years. If you didn’t read the $JBL fir…

Thesis: SIVE is a once-in-a-generation long due to its entrenched position in hyperscaler supply chains, extreme TAM expansion for pluggables and CPO, validation from JBL fireside transcript, moat from Ayar r…

new thesishigh

Photonics is nuanced and using ChatGPT/Gemini makes you miss all of it: 1. $SIVE is actually a chokepoint and partially a bottleneck. The reason it's a chokepoint is leading CPO/optical hyperscaler players go through Sivers, likely: Ayar. Celestial. Lightmatter. Lightellige…

Thesis: Sivers is a chokepoint and bottleneck for CPO lasers, with architecturally unique CW lasers used by leading hyperscaler players. Currently in development contracts, volume ramp expected in 2027. The c…

thesis updatehigh

@northyvt $AAOI is more pure manufacturing scale and I'm extremely bullish on them. So it's more like Furukawa + Innolight in my view? So extremely bullish for revenue ramp. $SIVE is just pure one-of-a-kind IP, where major CPO hyperscaler supplier seems to all use them, like …

Thesis: Sivers Semiconductors is a pure IP play in CPO lasers with major hyperscaler suppliers using them, while Applied Optoelectronics is a pure manufacturing scale play; both are extremely bullish.

view on X ↗SIVE · AAOI
thesis updatemedium

@IkaKnight_ Markets are kinda realizing US Gov is heavily backing $SIVE as you can see with direct US CHIPS Act funding. Since you see Sivers in $YSS Golden Dome supply chains (from allspace), and $RTX defense supply chains (chips act). But yeah Ericsson and SIvers are probab…

Thesis: Sivers is benefiting from US government backing via CHIPS Act, inclusion in YSS Golden Dome and RTX defense supply chains, and US-Sweden tech MOU with Ericsson, reinforcing its position as a key laser…

thesis updatehigh

@HarshaRenga96 I said this before but I have high conviction in $SIVE. I'm confident their UC Berkeley + $LITE executive team knows what IP to acquire. Since they've worked with Ayar and others from the start. Also helps that 22% of their company are PHDs so entire team is cr…

Thesis: High conviction in SIVE due to its leading position in lasers for CPO and 1.6T, strong team with UC Berkeley and LITE executive background, valuable IP moat, and recent market interest and funding.

new thesishigh

For $SIVE to become the next $80B+ $LITE. Sivers is the current laser kingmaker of the optical transition to CPO and 1.6T. They basically supply lasers to the leading players in the CPO space. From likely $MRVL Celestial, Lightmatter, Lightelligence, $POET, and others for …

Thesis: Sivers is positioned to become the laser kingmaker for the CPO and 1.6T optical transition, similar to LITE's growth from $2B to $80B, by expanding from laser supply to optical engine and transceiver …

new thesishigh

Wait until you realize that this is actually NASDAQ liquidity required for the US listing/float. And proceeds are expected go to $SIVE M&A (they hired 2 acquisition related board members). For photonics TAM/Revenue expansion. Not only that, all the small companies they worked…

Thesis: Sivers is positioned as the 'Kingmaker' for CPO photonics, using proceeds from NASDAQ listing to fund M&A for photonics TAM/Revenue expansion, with a strong track record of identifying successful acqu…

new thesishigh

$SIVE is literally the kingmaker for CPO: From ~ Lightmatter, Celestial, Ayar, Lightelligence early on. Now the leaders with massive $5-10B+ valuations. To the ASIC ecosystems like Marvell, Alchip, GUC. With O-Net mass producing ELS with Sivers for CPO. And Jabil mass produci…

Thesis: Sivers is the key supplier of lasers for CPO (Co-Packaged Optics), with its lasers central to major photonics ecosystems from Lightmatter, Celestial, Ayar, Lightelligence to ASIC ecosystems like Marve…

thesis updatehigh

A guide by Serenity on becoming a true Swedish local: 1. See crown jewel photonics company in $SIVE? 2. Get angry about 2024 revenue numbers, ignoring forward growth. 3. Encourage everyone to transfer control to America at the bottom, before the CPO supercycle 4. Be angry th…

Thesis: SIVE is a crown jewel photonics company benefiting from the CPO supercycle, with Jabil mass producing 1.6T LRO for hyperscalers starting H1 2027, and shorts being squeezed as MSCI inclusion and NASDAQ…

thesis updatehigh

Did you listen Sweden? > $SIVE MSCI Listing + structural inflow > $6.6M CHIPS act funding > Jabil 1.6T extreme demand, volume ramp > Apple next-gen Watch refresh likely using Sivers > 2 new board members related to M&A > Nasdaq listing inc The story keep…

Thesis: Sivers Semiconductors (SIVE) is building momentum with multiple catalysts: MSCI listing driving structural inflows, CHIPS Act funding, strong demand from Jabil, potential Apple Watch adoption, new boa…

new thesishigh

If people don’t realize why I’m so interested in $SIVE M&A. Sivers likely customers were: Lightmatter when they were tiny -> became $4B+ company. Lightelligence when they were tiny -> became $10B+ company. Ayar when they were tiny -> now funded by $NVDA, $AMD, and others. Ce…

Thesis: Sivers' past relationships with successful optical companies (Lightmatter, Lightelligence, Ayar, Celestial) and its ownership of a key laser chokepoint position it well for M&A of optical IP, now enab…

thesis updatehigh

@AndreasSch52269 It's probably due to extreme uncertainty risk for short sellers. > Since MSCI listing triggers tens of millions of new inflow for $SIVE in a week or two. > NASDAQ listing could be anytime > Earnings catalysts, with new pluggable partners > News about $JBL extre…

Thesis: Multiple near-term catalysts (MSCI listing, NASDAQ listing, earnings, JBL demand, M&A) create bullish setup for $SIVE, with high short interest adding fuel.

new thesishigh

@ShakespeareDad $SIVE is likely sole source for this specific 1.6T LRO from $JBL given the architectural uniqueness. It’s not a standard cw laser.

Thesis: $SIVE is likely the sole source for a specific 1.6T LRO with $JBL due to architectural uniqueness, implying a strong competitive moat.

new thesishigh

$SIVE mass production for 1.6T optical transceivers with $JBL: Is now earlier than expected per JP Morgan Fireside chat. Here's what they announced: > "Relatively dramatic moat" implied with $SIVE laser architectures > Extreme demand for their 1.6T, which was previously unk…

Thesis: Sivers' 1.6T laser mass production with Jabil is ramping earlier than expected with extreme demand, creating a strong revenue opportunity.

new thesishigh

Just putting it out there: $SIVE short interest is probably higher than 17%+ now. As lot of local Swedish hedge funds are very underwater, shorting Sivers. They're about to meet US institutions through: > MSCI inflow in 2 weeks. > NASDAQ Listing. > US CHIPS Act backstop. …

Thesis: SIVE has high short interest from underwater Swedish hedge funds. Upcoming catalysts (MSCI inflow, NASDAQ listing, US CHIPS Act) and optical supercycle revenue ramp will drive the stock up, squeezing …

new thesishigh

@ram_blings I personally think $SIVE ends up a $10B+ company in 2027, so 8-10x. $LITE did go from $2.8B to $80B in 2 years, so not really impossible do a 60x in the next few years if the stars align. They're going down the right path. > $LITE / UC Berkeley executives runnin…

Thesis: SIVE can replicate LITE's massive growth by following a similar playbook: experienced photonics executives, US government backing, NASDAQ listing, institutional private placement, downstream IP acquis…

new thesishigh

@Clearingkarma17 $SIVE just got MSCI inclusion and that's another likely tens of millions buying pressure in 2 weeks. Then there's new $6.6M CHIPS ACT funding coming in, which is an amazing capital injection. The largest thing is revenue implications from this CHIPS ACT develo…

Thesis: Sivers Semiconductors (SIVE) is bullish due to MSCI inclusion driving buying pressure and a new $6.6M CHIPS ACT award providing capital injection and revenue implications, with government backstopping…

new thesismedium

@MindQuest42 Sweden is literally like: "it's all over for Sivers" Next day: US government gives $SIVE 6.6M CHIPS ACT award lol.

Thesis: Despite negative sentiment from Sweden, SIVE receives a $6.6M CHIPS Act award from the US government, indicating strong US support and potential upside.

new thesishigh

When I see comments like this (and there are a lot) from retail investors: I immediately think they lack the technical depth. I'll walk through each one from $SIVE to $LPK: 1. Photonics TAM goes from $14B -> $154B In just two years time, and it's likely going to keep scaling…

Thesis: Post presents bullish theses on four photonics/advanced packaging plays: SIVE (CW laser supplier, expected to become next LITE), LPK (glass substrates, pure exposure, upcoming volume ramp), AAOI (larg…

view on X ↗SIVE · LPK · AAOI · IQE
new thesishigh

@DanilSer33 The new $SIVE / Ayar / AlChip / $AMZN trainium supply chain is more bullish than the recent $POET $50m -> $500m purchase order. Markets probably won’t see the connection between Ayar AlChip and $SIVE unless someone points it out though.

Thesis: The new supply chain connection between SIVE, Ayar, AlChip, and Amazon Trainium presents a stronger opportunity than the recent POET purchase order.

new thesismedium

If you didn't know $POET is up 22% premarket on a $50m purchase from Lumilens. Scaling to $500m with a longer term framework. As mentioned in Sivers 2025 annual report: $POET is ramping up H2 2026 with $SIVE. Any demand from these midstream players back to $SIVE as the laser…

Thesis: POET's large purchase and scaling plans are highly bullish for Sivers as the laser chokepoint, with demand flowing back to SIVE.

thesis updatehigh

@TLEROY5 I mean $SIVE delivered everything I wanted to hear on their optical side? -> Volume ramp starting H2 -> TAM expansion into pluggable transceivers -> Multiple new likely hyperscaler suppliers testing/qualifying their lasers for pluggable aside from $JBL. -> Win Semi cap…

Thesis: Sivers Semi's optical side is advancing: volume ramp in H2, TAM expansion into pluggable transceivers, multiple hyperscaler qualifications beyond JBL, and secured semiconductor capacity.

new thesishigh

$SIVE 2025 annual report analysis. TLDR: Extremely Bullish. Sivers main growth vector is CPO, but they've TAM expansioned to pluggable transcivers + multiple new qualifications/development. 1. "We are currently seeing great interest... testing our DFB lasers across multipl…

Thesis: Sivers Semiconductors has a bullish outlook driven by CPO growth, TAM expansion into pluggable transceivers, CW laser bottleneck positioning, and volume production scaling starting H2 2026.

Current Price
$79.50
via cornerstones
Return from entry
+791.26%
entry Mar 18, 2026 @ $8.92
Signal-day returns
+7 days+62.22%
+30 days+165.25%
Thesis Lifecycle
📝
updatedMay 26, 2026-1 conv

JBL's expansion into pluggable optical transceivers and CPO ecosystem (Ayar, POET, etc.) help SIVE bridge its valuation gap faster.

source ↗
📝
updatedMay 26, 2026

New optical transceiver customer hints from annual report support SIVE's growth.

source ↗
📝
updatedMay 27, 2026

EU Chips Act 2, specifically targeting photonics, benefits SIVE as Europe's leading photonics/laser company, which also received US CHIPS Act funding and is critical to Western supply chains.

source ↗
⚠️
review neededMay 27, 2026

Short sellers are using bot farms and local media to spread disinformation about SIVE, but the shorts may be squeezed as the truth emerges.

source ↗
📝
updatedMay 27, 2026+1 conv

SIVE is fundamentally compelling due to CPO technology, with valuation drivers from JBL's $1.6T opportunity and CPO ramp from players like Ayar. Short interest turning into long positions is an additional catalyst.

source ↗
📝
updatedMay 27, 2026-1 conv

Company SIVE is listed on EU Chips Act 2, which is a positive catalyst.

source ↗
📝
updatedMay 28, 2026

Ayar's Wiwynn announcement suggests potential rack-scale CPO deployments, with $SIVE as primary laser array supplier, leading to meaningful revenue even from modest rack deployments.

source ↗
📝
updatedMay 28, 2026+1 conv

JBL's mass production of 1.6T LRO using SIVE will generate material revenue in 3-10 months.

source ↗
📝
updatedMay 28, 2026

SIVE is the most compelling CPO/photonics exposure with strong catalysts including AlChip/Amazon private placements, Wiwynn CPO scale-up, JBL optical transceiver ramp, O-Net scaling, YSS acquisition, CHIPS Act funding, POET volume ramp, Apple laser usage, Lightelligence/Lightmatter links, Celestial ramp with MRVL, TFLN customers like Lightium, AMD/GFS CPO with SIVE as supplier, Ayar sole sourcing, Ayar funding, pluggable TAM expansion, Nasdaq listing, MSCI inclusion, M&A signals, NOK as likely customer, and Win Semi capacity advantage. The user believes earnings will be strongly positive and plans to acquire more ownership.

source ↗
📝
updatedMay 29, 2026

Forward growth from volume ramp in photonics is accelerating, with 77% growth in opportunity pipeline to $799m in a single quarter, validating the volume ramp thesis.

source ↗
📝
updatedMay 29, 2026

Forward revenue projections grew 77% in a single quarter, validating volume ramp expectations for SIVE. Multiple volume ramps are starting and will compound growth further.

source ↗
📝
updatedMay 29, 2026

77% sequential growth in forward revenue projections validates volume ramp expectations for $SIVE in the CPO supercycle.

source ↗
📝
updatedMay 29, 2026

$SIVE's 77% sequential revenue growth marks the start of the CPO supercycle, with expectations of exponential compounding through H2 2027.

source ↗
📝
updatedMay 29, 2026

Validation of SIVE thesis with $JBL volume ramp as photonics growth vector confirmed by management.

source ↗
📝
updatedMay 29, 2026

Sequential 77% growth in forward revenue pipeline indicates massive forward growth for SIVE, validating volume ramp expectations and CPO supercycle.

source ↗
📝
updatedMay 29, 2026

SIVE's earnings report shows 77% forward growth indications, $JBL volume ramp confirmation, and multiple production starts, marking the inflection point of the CPO supercycle with exponential growth expected over the next two years.

source ↗
📝
updatedMay 29, 2026

SIVE's entire revenue pipeline grew 77% in first 3 months, indicating CPO supercycle inflection likely leading to exponential growth.

source ↗
📝
updatedMay 29, 2026

SIVE shows extreme pricing power with demand outstripping supply, targets 60% gross margins, and has two technologies feeding into three supercycles, indicating massive revenue opportunities.

source ↗
📝
updatedMay 29, 2026

SIVE CEO's comments on demand outstripping supply and high gross margins derisk the company and indicate strong pricing power.

source ↗
📝
updatedMay 29, 2026

SIVE has extreme pricing power with 60% gross margins, compared to LITE's ~45-48%, and is at the early stage of a CPO supercycle with exponentially growing revenue pipelines.

source ↗